A SYNERGISTIC EFFECT BETWEEN ANTIIDIOTYPE ANTIBODIES AND ANTINEOPLASTIC DRUGS IN THE THERAPY OF A MURINE B-CELL TUMOR

被引：15

作者：

HURWITZ, E ^{[1
]}

BUROWSKI, D ^{[1
]}

KASHI, R ^{[1
]}

HOLLANDER, N ^{[1
]}

HAIMOVICH, J ^{[1
]}

机构：

[1] TEL AVIV UNIV,SACKLER FAC MED,DEPT HUMAN MICROBIOL,IL-69978 TEL AVIV,ISRAEL

来源：

INTERNATIONAL JOURNAL OF CANCER | 1986年 / 37卷 / 05期

关键词：

D O I：

10.1002/ijc.2910370515

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：739 / 745

页数：7

共 24 条

[1]

BRIDGES SH, 1984, CANCER RES, V44, P5051

[2]

DAVIES DAL, 1973, BRIT J CANCER, V28, P285

[3] PROTECTION OF MICE AGAINST SYNGENEIC LYMPHOMATA .2. COLLABORATION BETWEEN DRUGS AND ANTIBODIES [J].

DAVIES, DAL ;

BUCKHAM, S ;

MANSTONE, AJ .

BRITISH JOURNAL OF CANCER, 1974, 30 (04) :305-311

[4]

DAVIES DAL, 1974, CANCER RES, V34, P3040

[5]

FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0

[6]

HERYLN D, 1985, J IMMUNOL, V134, P1300

[7] SITE-DIRECTED CHEMOTHERAPY WITH A DRUG BOUND TO ANTI-IDIOTYPIC ANTIBODY TO A LYMPHOMA CELL-SURFACE IGM [J].

HURWITZ, E ;

KASHI, R ;

BUROWSKY, D ;

ARNON, R ;

HAIMOVICH, J .

INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (06) :745-748

[8]

KAWASE I, 1985, CANCER RES, V45, P1663

[9] SELECTIVE KILLING OF LEUKEMIA-CELLS BY ANTIBODY TOXIN CONJUGATES - IMPLICATIONS FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].

KROLICK, KA ;

UHR, JW ;

VITETTA, ES .

NATURE, 1982, 295 (5850) :604-605

[10] BCL1, A MURINE MODEL FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - USE OF THE SURFACE-IMMUNOGLOBULIN IDIOTYPE FOR THE DETECTION AND TREATMENT OF TUMOR [J].

KROLICK, KA ;

ISAKSON, PC ;

UHR, JW ;

VITETTA, ES .

IMMUNOLOGICAL REVIEWS, 1979, 48 :81-106

← 1 2 3 →